Tags |
|
|
Links |
|
|
Main Subject - Federal Trade Commission Vows to Fight Spyware and SPAM Fraud
The Federal Trade Commission has been telling the world how they w
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ill stop SPAM and what happened? Well since they started it went u
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
p some 3000 percent or more. Did they stop it? No. Did they slow i
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
down; who knows, I sure have not noticed, my guess is no way. But
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
they claim they have?
How can we trust our government to be hone
How can we trust our government to be hone
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
t with us, when they lie about such ridiculous stuff out there? I
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
mean come on this is comical, they say they need more budget money
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
for all these nifty programs like SPAM, Phishing and Spyware and
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
es they have filed a few cases and touted their legal prowess, but
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
they are losing the war on the Internet and so worried about Publ
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
c Relations sending out press releases to some 8800 news outlets s
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
omeone must be wondering if they are really just all show and no g
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
o.
I have wondered if they are actually misrepresenting themselve
I have wondered if they are actually misrepresenting themselve
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
and using these PR campaigns as shills. It is amazing to me that
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
an agency which clearly is a complete and total farce in my opinio
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
can get away with this crap year after year and yet not come clea
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
n to the American People?
If we cannot trust them on spyware, phi
If we cannot trust them on spyware, phi
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
shing and SPAM how can we trust them to check on the price gouging
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
issues legitimately with gasoline pump prices? Hmm? I would like s
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ome answers not further PR from the FTC. Consider all this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/81247/mainsubjects-Federal-Trade-Commission-Vows-to-Fight-Spyware-and-SPAM-Fraud.html">Federal Trade Commission Vows to Fight Spyware and SPAM Fraud</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/81247/mainsubjects-Federal-Trade-Commission-Vows-to-Fight-Spyware-and-SPAM-Fraud.html]Federal Trade Commission Vows to Fight Spyware and SPAM Fraud[/url]
Related Articles:
Organisational Culture for Continuous Improvement
Bookmark it:
|